We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
+11.86%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$1.54B
AUM Growth
-$2.36M
Cap. Flow
-$96.2M
Cap. Flow %
-6.24%
Top 10 Hldgs %
55.26%
Holding
142
New
22
Increased
21
Reduced
44
Closed
24

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$110M
2
HGV icon
Hilton Grand Vacations
HGV
+$16.3M
3
RDNW
RideNow Group
RDNW
+$13.5M
4
BVS icon
Bioventus
BVS
+$12.2M
5
IRON icon
Disc Medicine
IRON
+$7.68M

Top Sells

Rank Stock Value
1
COST icon
Costco
COST
+$40.9M
2
LNW
Light & Wonder
LNW
+$29.8M
3
DXPE icon
DXP Enterprises
DXPE
+$21.9M
4
MLKN icon
MillerKnoll
MLKN
+$11.2M
5
TNL icon
Travel + Leisure Co
TNL
+$11.2M

Sector Composition

Rank Sector Weight
1 Healthcare 31.93%
2 Consumer Discretionary 11.03%
3 Industrials 5.33%
4 Financials 4.5%
5 Technology 4.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PWP icon
51
Perella Weinberg Partners
PWP
$1.3B
$4.94M 0.32%
239,819
-265,474
-53% -$2.27M
RNG icon
52
RingCentral
RNG
$5.3B
$4.87M 0.32%
137,622
-30,000
-18% -$1.07M
IDYA icon
53
IDEAYA Biosciences
IDYA
$3.53B
$4.61M 0.3%
253,480
– –
ABEO icon
54
Abeona Therapeutics
ABEO
$427M
$4.19M 0.27%
+272,731
New +$1.02M
PNT
55
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$4.17M 0.27%
572,191
+374,408
+189% +$2.78M
WEBR
56
DELISTED
Weber Inc.
WEBR
$4.03M 0.26%
+500,000
New +$3.49M
TELA icon
57
TELA Bio
TELA
$37.6M
$4.01M 0.26%
349,002
– –
FULC icon
58
Fulcrum Therapeutics
FULC
$286M
$3.64M 0.24%
+500,000
New +$3.26M
APTO
59
DELISTED
Aptose Biosciences, Inc.
APTO
$3.51M 0.23%
13,451
-1,857
-12% -$499K
SSKN
60
DELISTED
Strata Skin Sciences
SSKN
$3.47M 0.23%
439,369
– –
MED icon
61
Medifast
MED
$135M
$3.46M 0.22%
+30,000
New +$3.49M
AAN
62
DELISTED
The Aaron's Company Inc
AAN
$3.45M 0.22%
288,572
+87,105
+43% +$933K
CDTX
63
DELISTED
Cidara Therapeutics
CDTX
$3.3M 0.21%
218,373
-9,587
-4% -$114K
MDXG icon
64
MiMedx Group
MDXG
$630M
$3.19M 0.21%
+1,147,524
New +$3.43M
ACER
65
DELISTED
Acer Therapeutics Inc
ACER
$3.08M 0.2%
1,226,191
+529,653
+76% +$909K
IRON icon
66
Disc Medicine
IRON
$3.03B
$3.06M 0.2%
162,762
+154,173
+1,795% +$7.68M
DHC
67
Diversified Healthcare Trust
DHC
$2.01B
$2.73M 0.18%
+4,215,000
New +$4.16M
AVTX icon
68
Avalo Therapeutics
AVTX
$1.04B
$2.73M 0.18%
2,253
-30
-1% -$39.1K
OPTN
69
DELISTED
OptiNose
OPTN
$2.68M 0.17%
+96,667
New +$3.67M
IMTXW
70
DELISTED
Immatics N.V. Warrants
IMTXW
$2.48M 0.16%
986,101
-1,331
-0.1% -$4.05K
SRL icon
71
Scully Royalty
SRL
$93.8M
$2.44M 0.16%
316,010
-2,483
-0.8% -$19.3K
MACK
72
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$2.41M 0.16%
210,000
-219,596
-51% -$1.81M
RILY icon
73
BRC Group Holdings
RILY
$302M
$2.34M 0.15%
68,296
– –
SYRE icon
74
Spyre Therapeutics
SYRE
$9.17B
$2.07M 0.13%
184,452
+36,021
+24% +$647K
ENVA icon
75
Enova International
ENVA
$6.39B
$2.04M 0.13%
+53,250
New +$1.94M
1 2
3
4 5

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return

Nantahala Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Nantahala Capital Management held 142 positions worth $1.54B, down 0.15% from $1.55B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Nantahala Capital Management withdrew a net $96.2M in Q4 2022, closing 24 positions and reducing 44 holdings. Its most notable exit was Costco, an estimated $40.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Nantahala Capital Management opened a new position in Hilton Grand Vacations worth $15.9M.

  • Nantahala Capital Management's largest Q4 2022 buy was Hilton Grand Vacations: 413,200 shares worth $15.9M.
  • Nantahala Capital Management added most to iShares Russell 2000 ETF in Q4 2022, an estimated $110M increase.
  • Nantahala Capital Management's biggest Q4 2022 reduction was DXP Enterprises, cutting an estimated $21.9M.
  • Nantahala Capital Management fully exited Costco in Q4 2022, selling an estimated $40.9M.
  • Nantahala Capital Management's ten largest holdings make up 55% of its $1.54B portfolio in Q4 2022.
  • Nantahala Capital Management opened 22 new positions and closed 24 in Q4 2022.
  • Nantahala Capital Management's portfolio value fell 0.15% quarter-over-quarter to $1.54B.

Based on Nantahala Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.